Literature DB >> 16423684

Phage therapy: facts and fiction.

Mikael Skurnik1, Eckhard Strauch.   

Abstract

Recent examples of the use of bacteriophages in controlling bacterial infections are presented, some of which show therapeutic promise. The therapeutic use of bacteriophages, possibly in combination with antibiotics, may be a valuable approach. However, it is also quite clear that the safe and controlled use of phage therapy will require detailed information on the properties and behavior of specific phage-bacterium systems, both in vitro and especially in vivo. In vivo susceptibility of bacterial pathogens to bacteriophages is still largely poorly understood and future research on more phage-bacterium systems has to be undertaken to define the requirements for successful phage treatments.

Entities:  

Mesh:

Year:  2005        PMID: 16423684     DOI: 10.1016/j.ijmm.2005.09.002

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  66 in total

1.  Selection and characterization of a multivalent Salmonella phage and its production in a nonpathogenic Escherichia coli strain.

Authors:  S B Santos; E Fernandes; C M Carvalho; S Sillankorva; V N Krylov; E A Pleteneva; O V Shaburova; A Nicolau; E C Ferreira; J Azeredo
Journal:  Appl Environ Microbiol       Date:  2010-09-03       Impact factor: 4.792

2.  Phage therapy to control multidrug-resistant Pseudomonas aeruginosa skin infections: in vitro and ex vivo experiments.

Authors:  A Vieira; Y J Silva; A Cunha; N C M Gomes; H-W Ackermann; A Almeida
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-10       Impact factor: 3.267

3.  Fluorescence correlation spectroscopy to study diffusion and reaction of bacteriophages inside biofilms.

Authors:  R Briandet; P Lacroix-Gueu; M Renault; S Lecart; T Meylheuc; E Bidnenko; K Steenkeste; M-N Bellon-Fontaine; M-P Fontaine-Aupart
Journal:  Appl Environ Microbiol       Date:  2008-02-01       Impact factor: 4.792

4.  Beyond antibiotics?

Authors:  L E Nicolle
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

5.  Pseudomonas aeruginosa phage PaP1 DNA polymerase is an A-family DNA polymerase demonstrating ssDNA and dsDNA 3'-5' exonuclease activity.

Authors:  Binyan Liu; Shiling Gu; Nengsong Liang; Mei Xiong; Qizhen Xue; Shuguang Lu; Fuquan Hu; Huidong Zhang
Journal:  Virus Genes       Date:  2016-04-06       Impact factor: 2.332

6.  Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.

Authors:  Erin E Gill; Octavio L Franco; Robert E W Hancock
Journal:  Chem Biol Drug Des       Date:  2015-01       Impact factor: 2.817

7.  Characterization of Salmonella bacteriophages isolated from swine lagoon effluent.

Authors:  Michael R McLaughlin; Rodney A King
Journal:  Curr Microbiol       Date:  2007-11-10       Impact factor: 2.188

8.  The effects of staphylococcal bacteriophage lysates on cancer cells in vitro.

Authors:  Krystyna Dabrowska; Grzegorz Skaradziński; Aneta Kurzepa; Barbara Owczarek; Maciej Zaczek; Beata Weber-Dabrowska; Joanna Wietrzyk; Magdalena Maciejewska; Paulina Budynek; Andrzej Górski
Journal:  Clin Exp Med       Date:  2009-09-25       Impact factor: 3.984

9.  Isolation and Comparative Genomic Analysis of T1-Like Shigella Bacteriophage pSf-2.

Authors:  Jin Woo Jun; Hyoun Joong Kim; Sae Kil Yun; Ji Young Chai; Byeong Chun Lee; Se Chang Park
Journal:  Curr Microbiol       Date:  2015-11-26       Impact factor: 2.188

10.  The effect of bacteriophages T4 and HAP1 on in vitro melanoma migration.

Authors:  Krystyna Dabrowska; Grzegorz Skaradziński; Paulina Jończyk; Aneta Kurzepa; Joanna Wietrzyk; Barbara Owczarek; Maciej Zaczek; Kinga Switała-Jeleń; Janusz Boratyński; Gryzelda Poźniak; Magdalena Maciejewska; Andrzej Górski
Journal:  BMC Microbiol       Date:  2009-01-20       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.